Target intelligence / Profile preview

Campylobacter jejuni surface antigen

Molecular classification
Bacterial surface protein, Lipooligosaccharide, Glycoprotein, Adhesin, Porin
01

Overview

Campylobacter jejuni surface antigens comprise a diverse array of molecules, including proteins and lipooligosaccharides (LOS), that are exposed on the bacterial exterior and are vital for host-pathogen interactions. Key antigenic components include the flagellar proteins (FlaA and FlaB), the major outer membrane protein (MOMP), and various adhesins such as CadF and Peb1, which facilitate bacterial motility through the intestinal mucus and attachment to epithelial cells (Poly & Guerry, 2008). These antigens are the primary targets of the host immune system during campylobacteriosis, the leading cause of bacterial foodborne gastroenteritis worldwide (Young et al., 2007). A critical clinical aspect of these antigens is the presence of sialylated LOS structures that can mimic human gangliosides, potentially triggering the autoimmune peripheral neuropathy known as Guillain-Barré syndrome (Yuki, 2001). Therapeutic strategies targeting these antigens primarily focus on vaccine development and passive immunization to prevent colonization, though researchers must carefully navigate the risks of molecular mimicry to ensure safety (Riddle et al., 2012).

Other names
C. jejuni surface proteinsCampylobacter jejuni outer membrane antigensCampylobacter jejuni flagellar antigensCampylobacter jejuni cell surface components
02

Mechanism of action

Induction of neutralizing mucosal and systemic antibodies (IgA and IgG) to inhibit bacterial motility, adherence, and colonization of the intestinal epithelium.

03

Biological functions

Bacterial adhesionBacterial motilityHost cell invasionImmune evasionMembrane integrityNutrient transport
04

Disease associations

InfectionCampylobacteriosisGuillain-Barré syndromeMiller Fisher syndromeReactive arthritis
05

Safety considerations

Molecular mimicry between bacterial lipooligosaccharides and human nerve gangliosidesRisk of inducing Guillain-Barré syndrome through cross-reactive antibodiesHigh antigenic variability among different Campylobacter strainsPotential for exacerbating inflammatory bowel conditions
06

Interacting drugs

ACE-527

3 more in the full profile.

07

Biomarkers

Anti-Campylobacter jejuni IgG titersAnti-Campylobacter jejuni IgA titersStool Campylobacter antigenAnti-ganglioside antibodies (e.g., anti-GM1)

Beyond the preview

Go deeper on Campylobacter jejuni surface antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Campylobacter jejuni surface antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call